MGX

Metagenomi Therapeutics, Inc.

$1.29 -0.03 (-2.27%) At close · Jul 8

Market Cap

$48.56M

Shares

37,646,858

Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.

Revenue & result across quarters

Revenue ($B) YoY up YoY down artefacts

LATEST ▼69.8% '26 Q1 26-05-11 ▼59.3% '25 Q4 26-03-05 ▼24.8% '25 Q3 25-11-12 ▼57.5% '25 Q2 25-08-12 ▼63% '25 Q1 25-05-13 · '24 Q4 25-03-17 · '24 Q3 24-11-13 · '24 Q2 24-08-14 · '24 Q1 24-05-01

Metagenomi Therapeutics, Inc. Q1 FY2026 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q4 FY2025 Earnings Call

Audio Transcript Slides 8-K10-K

Metagenomi Therapeutics, Inc. Q3 FY2025 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q2 FY2025 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q1 FY2025 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q4 FY2024 Earnings Call

Audio Transcript Slides 8-K10-K

Metagenomi Therapeutics, Inc. Q3 FY2024 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q2 FY2024 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q1 FY2024 Earnings Call

Audio Transcript Slides 8-K10-Q

Metagenomi Therapeutics, Inc. Q4 FY2023 Earnings Call

Results not yet reported

Audio Transcript Slides 8-K10-K

Showing 1–10 of 10 earnings calls

Key facts CIK 1785279 CUSIP 59102M104 Visit website Investor relations